Answers from the Lab

Ann Moyer, M.D., Ph.D., and Paul Jannetto, Ph.D., explain how precision therapeutics can improve treatment for patients with major depressive disorder. The optimal antidepressant medication and dose vary among individuals. Pharmacogenomic testing and therapeutic drug monitoring can guide clinicians to choose the most-effective treatment for each patient.

Show Notes

(00:31)
 Can you both tell us a little bit about yourselves and your backgrounds? Dr. Moyer, do you want to start?

(01:51)
 Your background, Dr. Janetto?

(02:47) 
 Please provide an overview of major depressive disorder and the test that Mayo Clinic Laboratories has available for therapeutic drug monitoring as well as pharmacogenomics.

(07:05)
 Which patients should have this testing, and when should it be performed?
 
(11:33)
 What alternative test options are available, and how do they compare?

(15:37)
 How are the results used in patient care?

What is Answers from the Lab?

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.